Back to Browse Journals » Drug Design, Development and Therapy » Volume 3

Analysis of HSP90-related folds with MED-SuMo classification approach

Authors Olivia Doppelt-Azeroual, Fabrice Moriaud, François Delfaud, Alexandre G de Brevern

Published Date February 2009 Volume 2009:3 Pages 59—72

DOI http://dx.doi.org/10.2147/DDDT.S4706

Published 26 February 2009

Olivia Doppelt-Azeroual1,2, Fabrice Moriaud1, François Delfaud1, Alexandre G de Brevern2

1MEDIT SA, Palaiseau, France; 2INSERM UMR-S 726, Equipe de Bioinformatique Génomique and Moléculaire, (EBGM), DSIMB, Institut National de Transfusion Sanguine (INTS), Université Paris Diderot, Paris, France

Abstract: Three-dimensional structural information is critical for understanding functional protein properties and the precise mechanisms of protein functions implicated in physiological and pathological processes. Comparison and detection of protein binding sites are key steps for annotating structures with functional predictions and are extremely valuable steps in a drug design process. In this research area, MED-SuMo is a powerful technology to detect and characterize similar local regions on protein surfaces. Each amino acid residue’s potential chemical interactions are represented by specific surface chemical features (SCFs). The MED-SuMo heuristic is based on the representation of binding sites by a graph structure suitable for exploration by an efficient comparison algorithm. We use this approach to analyze one particular SCOP superfamily which includes HSP90 chaperone, MutL/DNA topoisomerase, histidine kinases, and α-ketoacid dehydrogenase kinase C (BCK). They share a common fold and a common region for ATP-binding. To analyze both similar and differing features of this fold, we use a novel classification method, the MED-SuMo multi approach (MED-SMA). We highlight common and distinct features of these proteins. The different clusters created by MED-SMA yield interesting observations. For instance, one cluster gathers three types of proteins (HSP90, topoisomerase VI, and BCK) which all bind the drug radicicol.

Keywords: functional classification, surface similarity, protein surface chemical feature, radicicol binding

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Fungus-mediated biological synthesis of gold nanoparticles: potential in detection of liver cancer

Chauhan A, Zubair S, Tufail S, Sherwani A, Sajid M, Raman SC, Azam A, Owais M

International Journal of Nanomedicine 2011, 6:2305-2319

Published Date: 12 October 2011

Comparative assessment of biologics in treatment of psoriasis: drug design and clinical effectiveness of ustekinumab

Ignacio Garcia-Valladares, Raquel Cuchacovich, Luis R Espinoza

Drug Design, Development and Therapy 2011, 5:41-49

Published Date: 10 January 2011

Neurotransmitter testing of the urine: a comprehensive analysis

Marty Hinz, Alvin Stein, George Trachte, et al

Research and Reports in Urology 2010, 2:177-183

Published Date: 7 October 2010

Pleiotropic vasoprotective effects of statins: The chicken or the egg?

Dimitrios Kirmizis, Dimitrios Chatzidimitriou

Drug Design, Development and Therapy 2009, 3:191-204

Published Date: 10 June 2009

Capillary telangiectasia mimicking an active inflammatory MS-lesion in repetitive cMRIs

Michael Harzheim, Claudia Gemmel, Bernd Sommer, Ulf Kallweit, Dieter Pöhlau

Reports in Medical Imaging 2008, 1:1-2

Published Date: 24 November 2008

Structure-based design of anticancer prodrug PABA/NO

Xinhua Ji, Ajai Pal, Ravi Kalathur, Xun Hu, Yijun Gu, et al

Drug Design, Development and Therapy 2008, 2:123-130

Published Date: 11 August 2008